This process is imperative in the maintenance of healthy immune responses, as patients with X-linked lymphoproliferative disease due to SLAM-associated protein (SAP) deficiency (XLP-1) can perish from Epstein–Barr virus-induced fulminant infectious mononucleosis. The gene discussed is SH2D1A; the disease is X-linked lymphoproliferative disease.